Reuters reports that an oscillating field stimulator has been tested in a Phase 1 human trial (a clinical trial conducted to evaluate the safety of a therapy; Phase 2 and 3 are to be completed before FDA approval), and results are encouraging:
NEW YORK (Reuters Health) – Early tests are raising hopes that a new device can help people who’ve injured their spinal cord.
Implantation of an oscillating field stimulator, which generates an electrical field, is a safe, well-tolerated treatment that may improve motor and sensory function in such patients, findings from a pilot study suggest.
The device, which was developed at Purdue University, is placed near the site of injury and is designed to stimulate nerves to regenerate and, it’s hoped, restore some degree of function.
After seeing encouraging results in dogs with spinal cord injury, Dr. Scott Shapiro, from Indiana University School of Medicine, Indianapolis, and colleagues tested the device in humans. The researchers’ findings appear in the Journal of Neurosurgery-Spine.